{"id":473763,"date":"2010-03-26T03:20:27","date_gmt":"2010-03-26T07:20:27","guid":{"rendered":"http:\/\/www.xconomy.com\/?p=70484"},"modified":"2010-03-26T03:20:27","modified_gmt":"2010-03-26T07:20:27","slug":"adaptive-tcr-a-fred-hutch-spinoff-nabs-4-5m-to-uncover-immune-system-secrets","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/473763","title":{"rendered":"Adaptive TCR, a Fred Hutch Spinoff, Nabs $4.5M to Uncover Immune System Secrets"},"content":{"rendered":"\n<div style=\"text-transform:uppercase\"><a href=\"http:\/\/www.xconomy.com\/tag\/Biotech\/\">Biotech<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/VC\/\">VC<\/a>, <a href=\"http:\/\/www.xconomy.com\/tag\/startups\/\">startups<\/a><\/div>\n<p>\t\t<a rel=\"attachment wp-att-70485\" href=\"http:\/\/www.xconomy.com\/?attachment_id=70485\"><img loading=\"lazy\" decoding=\"async\" style=\"float:right;margin: 0px 0 5px 15px;\" class=\"alignnone size-thumbnail wp-image-70485\" title=\"adaptive\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/images\/2010\/03\/adaptive-180x55.png\" alt=\"adaptive\" width=\"180\" height=\"55\" \/><\/a><br \/>\n\t\t<strong>Luke Timmerman wrote:<\/strong><\/p>\n<p>Seattle experts in computer science and immunology are rallying around a new spinoff company from the Fred Hutchinson Cancer Research Center.<\/p>\n<p>Seattle-based <a href=\"http:\/\/www.adaptivetcr.com\/faces\/x\/index.xhtml\">Adaptive TCR<\/a> has nailed down a <a href=\"http:\/\/www.adaptivetcr.com\/press\/adaptiverelease2.pdf\">$4.5 million<\/a> round of angel investment to get up and running, Xconomy has learned. The basic concept is to provide scientists with a high-speed, high-resolution look into the vast diversity of T-cells of the adaptive immune system that we all produce to ward off infections, and which sometimes go awry and cause disease.<\/p>\n<p>This company wasn&#8217;t backed by the usual venture capital suspects in Seattle biotech, and it has an unusual backstory. Adaptive&#8217;s scientific co-founders are a pair of Hutch researchers who are first-time entrepreneurs in their 30s: <a href=\"http:\/\/myprofile.cos.com\/hrobins\">Harlan Robins<\/a>, a particle physicist who turned to genomics a decade ago to tackle its daunting math, and <a href=\"http:\/\/www.fhcrc.org\/science\/phs\/cprp\/faculty\/carlson.html\">Chris Carlson<\/a>, a geneticist and molecular biologist. <a href=\"http:\/\/www.adaptivetcr.com\/faces\/x\/team.xhtml#Founders\">Chad Robins<\/a>, Harlan&#8217;s brother, has signed on as the founding president and CEO. Chad, who has a Wharton School business degree and experience with investment banking and hedge funds, wrote the original business plan and tapped his Rolodex to raise the company&#8217;s seed capital.<\/p>\n<p>The founding scientific advisory board includes some big names. They include <a href=\"http:\/\/www.sns.ias.edu\/~alevine\/\">Arnold Levine<\/a> of the Institute for Advanced Study in Princeton, NJ; <a href=\"http:\/\/www.benaroyaresearch.org\/our-research\/faculty\/gerald-nepom\">Gerald Nepom<\/a>, the director of the Benaroya Research Institute in Seattle; <a href=\"http:\/\/myprofile.cos.com\/ehwarren\">Edus Houston Warren<\/a> of the University of Washington and Fred Hutch, as well as two other prominent genetic researchers from the UW who aren&#8217;t being named yet.<a rel=\"attachment wp-att-4890\" href=\"http:\/\/www.xconomy.com\/seattle\/2008\/09\/17\/taking-charge-of-tech-transfer-at-the-hutch-qa-with-ulrich-mueller\/attachment\/hutchlogo1\/\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-thumbnail wp-image-4890\" title=\"hutchlogo1\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/images\/2008\/09\/hutchlogo1-180x47.gif\" alt=\"hutchlogo1\" width=\"180\" height=\"47\" \/><\/a><\/p>\n<p>&#8220;I&#8217;ve been talking to my brother for 20 years, and saying &#8216;You&#8217;re a smart guy, when are we going to do a business together?&#8217;&#8221; Chad Robins says. &#8220;He&#8217;s never been interested before. Then he called me last February.&#8221;<\/p>\n<p>That was a little over a year ago. Now the business is taking shape with a founding team of four employees who have subleased some office space in South Lake Union from VLST.<\/p>\n<p>Adaptive TCR is built on using high-speed gene sequencing instruments that capture data from biological samples, and combining it with some pretty heavy duty math that&#8217;s executed by proprietary software.<\/p>\n<p>The problem is certainly complicated enough to excite a string theorist like Harlan Robins. While scientists know that the 3 billion letters of DNA that make up a genome are consistent in every human cell, that&#8217;s not a fixed number that applies to immune system T-cells. The DNA in T-cells gets shuffled as they mature, allowing the cells to recognize a foreign invader like a virus. Humans have evolved an ability to adapt to these invaders, by building up a vast repertoire of T-cells with memory for a certain pathogen. This vast array of T-cell variation is something that scientists haven&#8217;t been able<span class=\"read_more\"> <a href=\"http:\/\/www.xconomy.com\/seattle\/2010\/03\/26\/adaptive-tcr-a-fred-hutch-spinoff-nabs-4-5m-to-uncover-immune-system-secrets\/2\/\"> &#8230;Next Page &raquo;<\/a><\/span><\/p>\n<div class=\"postFooter\"><a href=\"http:\/\/www.xconomy.com\/seattle\/2010\/03\/26\/adaptive-tcr-a-fred-hutch-spinoff-nabs-4-5m-to-uncover-immune-system-secrets\/#comments\">Comments<\/a> | <a href=http:\/\/www.xconomy.com\/reprints\/>Reprints<\/a> | Share: &nbsp;<br \/>\n<a href=\"http:\/\/twitter.com\/home?status=RT%20@Xconomy%20Adaptive%20TCR,%20a%20Fred%20Hutch%20Spinoff,%20Nabs%20$4.5M%20to%20Uncover%20Immune%20System%20Secrets%20http:\/\/xconomy.com\/?p=70484\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/twitter.gif\" alt=\"Retweet\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/www.facebook.com\/sharer.php?u=http:\/\/www.xconomy.com\/seattle\/2010\/03\/26\/adaptive-tcr-a-fred-hutch-spinoff-nabs-4-5m-to-uncover-immune-system-secrets\/&#038;t=Adaptive%20TCR,%20a%20Fred%20Hutch%20Spinoff,%20Nabs%20$4.5M%20to%20Uncover%20Immune%20System%20Secrets\"  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/facebook.gif\" alt=\"Facebook\"\/><\/a><br \/>\n&nbsp;<a href=http:\/\/www.xconomy.com\/seattle\/2010\/03\/26\/adaptive-tcr-a-fred-hutch-spinoff-nabs-4-5m-to-uncover-immune-system-secrets\/email\/  rel=\"nofollow\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/email.gif\" alt=\"Email\"\/><\/a><br \/>\n&nbsp;<a href=\"http:\/\/sharethis.com\/item?publisher=bfda184d-6684-4f7a-a23f-ca4ed4db9287&amp;title=Adaptive+TCR%2C+a+Fred+Hutch+Spinoff%2C+Nabs+%244.5M+to+Uncover+Immune+System+Secrets&amp;url=http%3A%2F%2Fwww.xconomy.com%2Fseattle%2F2010%2F03%2F26%2Fadaptive-tcr-a-fred-hutch-spinoff-nabs-4-5m-to-uncover-immune-system-secrets%2F\"><img decoding=\"async\" src=\"http:\/\/www.xconomy.com\/wordpress\/wp-content\/themes\/xconomy\/images\/share.gif\" alt=\"Share\"\/><\/a>\n<\/div>\n<p>\t     \t\t<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<br clear=\"both\" style=\"clear: both;\"\/><br \/>\n<a href=\"http:\/\/ads.pheedo.com\/click.phdo?s=bc1ee2038859587a004cff41b0c250d2&#038;p=1\"><img decoding=\"async\" alt=\"\" style=\"border: 0;\" border=\"0\" src=\"http:\/\/ads.pheedo.com\/img.phdo?s=bc1ee2038859587a004cff41b0c250d2&#038;p=1\"\/><\/a><br \/>\n<!-- foo --><\/p>\n<p><a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/e4fGSVMldpSBaSToEO3bfHSeYH0\/0\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/e4fGSVMldpSBaSToEO3bfHSeYH0\/0\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><br \/>\n<a href=\"http:\/\/feedads.g.doubleclick.net\/~a\/e4fGSVMldpSBaSToEO3bfHSeYH0\/1\/da\"><img decoding=\"async\" src=\"http:\/\/feedads.g.doubleclick.net\/~a\/e4fGSVMldpSBaSToEO3bfHSeYH0\/1\/di\" border=\"0\" ismap=\"true\"><\/img><\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"http:\/\/feeds.feedburner.com\/~r\/Xconomy_Full\/~4\/EjZJf3QI3xY\" height=\"1\" width=\"1\"\/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Biotech, VC, startups Luke Timmerman wrote: Seattle experts in computer science and immunology are rallying around a new spinoff company from the Fred Hutchinson Cancer Research Center. Seattle-based Adaptive TCR has nailed down a $4.5 million round of angel investment to get up and running, Xconomy has learned. The basic concept is to provide scientists [&hellip;]<\/p>\n","protected":false},"author":1192,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7,10],"tags":[],"class_list":["post-473763","post","type-post","status-publish","format-standard","hentry","category-news","category-software"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/473763","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1192"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=473763"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/473763\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=473763"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=473763"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=473763"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}